nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Hexylcaine—SCN5A—dilated cardiomyopathy	0.0286	1	CrCbGaD
Glycopyrrolate—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0125	0.0205	CcSEcCtD
Glycopyrrolate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0121	0.0198	CcSEcCtD
Glycopyrrolate—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0115	0.0189	CcSEcCtD
Glycopyrrolate—Bladder pain—Furosemide—dilated cardiomyopathy	0.0106	0.0174	CcSEcCtD
Glycopyrrolate—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00881	0.0145	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00881	0.0144	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00861	0.0141	CcSEcCtD
Glycopyrrolate—Cystitis—Lisinopril—dilated cardiomyopathy	0.00851	0.014	CcSEcCtD
Glycopyrrolate—Photophobia—Lisinopril—dilated cardiomyopathy	0.00827	0.0136	CcSEcCtD
Glycopyrrolate—Irritability—Furosemide—dilated cardiomyopathy	0.00814	0.0133	CcSEcCtD
Glycopyrrolate—Urinary retention—Furosemide—dilated cardiomyopathy	0.00811	0.0133	CcSEcCtD
Glycopyrrolate—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00797	0.0131	CcSEcCtD
Glycopyrrolate—Dehydration—Furosemide—dilated cardiomyopathy	0.00793	0.013	CcSEcCtD
Glycopyrrolate—Confusional state—Spironolactone—dilated cardiomyopathy	0.00777	0.0127	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0077	0.0126	CcSEcCtD
Glycopyrrolate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00742	0.0122	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00722	0.0118	CcSEcCtD
Glycopyrrolate—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00702	0.0115	CcSEcCtD
Glycopyrrolate—Somnolence—Spironolactone—dilated cardiomyopathy	0.00685	0.0112	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00675	0.0111	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00665	0.0109	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00665	0.0109	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00661	0.0108	CcSEcCtD
Glycopyrrolate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00657	0.0108	CcSEcCtD
Glycopyrrolate—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0064	0.0105	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00635	0.0104	CcSEcCtD
Glycopyrrolate—Sweating—Furosemide—dilated cardiomyopathy	0.0063	0.0103	CcSEcCtD
Glycopyrrolate—Urticaria—Spironolactone—dilated cardiomyopathy	0.00612	0.01	CcSEcCtD
Glycopyrrolate—Irritability—Lisinopril—dilated cardiomyopathy	0.0061	0.01	CcSEcCtD
Glycopyrrolate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00609	0.00999	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00608	0.00998	CcSEcCtD
Glycopyrrolate—Dehydration—Lisinopril—dilated cardiomyopathy	0.00595	0.00976	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00582	0.00955	CcSEcCtD
Glycopyrrolate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00578	0.00948	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00572	0.00938	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00567	0.00931	CcSEcCtD
Glycopyrrolate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00545	0.00894	CcSEcCtD
Glycopyrrolate—Dysuria—Lisinopril—dilated cardiomyopathy	0.00517	0.00848	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00514	0.00843	CcSEcCtD
Glycopyrrolate—Malnutrition—Furosemide—dilated cardiomyopathy	0.00513	0.00842	CcSEcCtD
Glycopyrrolate—Erythema—Furosemide—dilated cardiomyopathy	0.00513	0.00842	CcSEcCtD
Glycopyrrolate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00509	0.00835	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00509	0.00835	CcSEcCtD
Glycopyrrolate—Flatulence—Furosemide—dilated cardiomyopathy	0.00506	0.0083	CcSEcCtD
Glycopyrrolate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00503	0.00825	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00499	0.00818	CcSEcCtD
Glycopyrrolate—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00496	0.00813	CcSEcCtD
Glycopyrrolate—Vomiting—Spironolactone—dilated cardiomyopathy	0.0049	0.00803	CcSEcCtD
Glycopyrrolate—Rash—Spironolactone—dilated cardiomyopathy	0.00486	0.00797	CcSEcCtD
Glycopyrrolate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00485	0.00796	CcSEcCtD
Glycopyrrolate—Vision blurred—Furosemide—dilated cardiomyopathy	0.00484	0.00794	CcSEcCtD
Glycopyrrolate—Headache—Spironolactone—dilated cardiomyopathy	0.00482	0.00791	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00479	0.00786	CcSEcCtD
Glycopyrrolate—Sweating—Lisinopril—dilated cardiomyopathy	0.00473	0.00775	CcSEcCtD
Glycopyrrolate—Agitation—Furosemide—dilated cardiomyopathy	0.00472	0.00774	CcSEcCtD
Glycopyrrolate—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00465	0.00763	CcSEcCtD
Glycopyrrolate—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00462	0.00759	CcSEcCtD
Glycopyrrolate—Nausea—Spironolactone—dilated cardiomyopathy	0.00457	0.0075	CcSEcCtD
Glycopyrrolate—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00444	0.00728	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00437	0.00717	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00434	0.00712	CcSEcCtD
Glycopyrrolate—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00434	0.00712	CcSEcCtD
Glycopyrrolate—Dry mouth—Furosemide—dilated cardiomyopathy	0.00427	0.00701	CcSEcCtD
Glycopyrrolate—Confusional state—Furosemide—dilated cardiomyopathy	0.00422	0.00693	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00419	0.00687	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00411	0.00674	CcSEcCtD
Glycopyrrolate—Flushing—Lisinopril—dilated cardiomyopathy	0.00411	0.00674	CcSEcCtD
Glycopyrrolate—Skin disorder—Furosemide—dilated cardiomyopathy	0.00407	0.00668	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00405	0.00664	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00399	0.00654	CcSEcCtD
Glycopyrrolate—Hypotension—Furosemide—dilated cardiomyopathy	0.00392	0.00642	CcSEcCtD
Glycopyrrolate—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00388	0.00636	CcSEcCtD
Glycopyrrolate—Erythema—Lisinopril—dilated cardiomyopathy	0.00385	0.00632	CcSEcCtD
Glycopyrrolate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00385	0.00632	CcSEcCtD
Glycopyrrolate—Flatulence—Lisinopril—dilated cardiomyopathy	0.0038	0.00623	CcSEcCtD
Glycopyrrolate—Tension—Lisinopril—dilated cardiomyopathy	0.00378	0.0062	CcSEcCtD
Glycopyrrolate—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00377	0.00619	CcSEcCtD
Glycopyrrolate—Nervousness—Lisinopril—dilated cardiomyopathy	0.00374	0.00614	CcSEcCtD
Glycopyrrolate—Somnolence—Furosemide—dilated cardiomyopathy	0.00372	0.00611	CcSEcCtD
Glycopyrrolate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00363	0.00596	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00362	0.00593	CcSEcCtD
Glycopyrrolate—Fatigue—Furosemide—dilated cardiomyopathy	0.00361	0.00593	CcSEcCtD
Glycopyrrolate—Pain—Furosemide—dilated cardiomyopathy	0.00358	0.00588	CcSEcCtD
Glycopyrrolate—Constipation—Furosemide—dilated cardiomyopathy	0.00358	0.00588	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00345	0.00566	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00343	0.00562	CcSEcCtD
Glycopyrrolate—Palpitations—Lisinopril—dilated cardiomyopathy	0.0034	0.00558	CcSEcCtD
Glycopyrrolate—Urticaria—Furosemide—dilated cardiomyopathy	0.00333	0.00546	CcSEcCtD
Glycopyrrolate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00331	0.00543	CcSEcCtD
Glycopyrrolate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00331	0.00543	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00326	0.00534	CcSEcCtD
Glycopyrrolate—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00321	0.00526	CcSEcCtD
Glycopyrrolate—Confusional state—Lisinopril—dilated cardiomyopathy	0.00317	0.0052	CcSEcCtD
Glycopyrrolate—Oedema—Lisinopril—dilated cardiomyopathy	0.00314	0.00516	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00314	0.00516	CcSEcCtD
Glycopyrrolate—Infection—Lisinopril—dilated cardiomyopathy	0.00312	0.00512	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00309	0.00506	CcSEcCtD
Glycopyrrolate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00307	0.00503	CcSEcCtD
Glycopyrrolate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00305	0.00501	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00304	0.00499	CcSEcCtD
Glycopyrrolate—Asthenia—Furosemide—dilated cardiomyopathy	0.00301	0.00493	CcSEcCtD
Glycopyrrolate—Pruritus—Furosemide—dilated cardiomyopathy	0.00296	0.00486	CcSEcCtD
Glycopyrrolate—Hypotension—Lisinopril—dilated cardiomyopathy	0.00294	0.00482	CcSEcCtD
Glycopyrrolate—Insomnia—Lisinopril—dilated cardiomyopathy	0.00284	0.00466	CcSEcCtD
Glycopyrrolate—Somnolence—Lisinopril—dilated cardiomyopathy	0.00279	0.00458	CcSEcCtD
Glycopyrrolate—Dizziness—Furosemide—dilated cardiomyopathy	0.00277	0.00455	CcSEcCtD
Glycopyrrolate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00277	0.00454	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00271	0.00445	CcSEcCtD
Glycopyrrolate—Fatigue—Lisinopril—dilated cardiomyopathy	0.00271	0.00445	CcSEcCtD
Glycopyrrolate—Constipation—Lisinopril—dilated cardiomyopathy	0.00269	0.00441	CcSEcCtD
Glycopyrrolate—Pain—Lisinopril—dilated cardiomyopathy	0.00269	0.00441	CcSEcCtD
Glycopyrrolate—Vomiting—Furosemide—dilated cardiomyopathy	0.00266	0.00437	CcSEcCtD
Glycopyrrolate—Rash—Furosemide—dilated cardiomyopathy	0.00264	0.00433	CcSEcCtD
Glycopyrrolate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00264	0.00433	CcSEcCtD
Glycopyrrolate—Headache—Furosemide—dilated cardiomyopathy	0.00262	0.00431	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00259	0.00425	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00257	0.00422	CcSEcCtD
Glycopyrrolate—Urticaria—Lisinopril—dilated cardiomyopathy	0.0025	0.0041	CcSEcCtD
Glycopyrrolate—Nausea—Furosemide—dilated cardiomyopathy	0.00249	0.00408	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00249	0.00408	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00249	0.00408	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00232	0.0038	CcSEcCtD
Glycopyrrolate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00226	0.0037	CcSEcCtD
Glycopyrrolate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00222	0.00365	CcSEcCtD
Glycopyrrolate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00208	0.00341	CcSEcCtD
Glycopyrrolate—Vomiting—Lisinopril—dilated cardiomyopathy	0.002	0.00328	CcSEcCtD
Glycopyrrolate—Rash—Lisinopril—dilated cardiomyopathy	0.00198	0.00325	CcSEcCtD
Glycopyrrolate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00198	0.00325	CcSEcCtD
Glycopyrrolate—Headache—Lisinopril—dilated cardiomyopathy	0.00197	0.00323	CcSEcCtD
Glycopyrrolate—Nausea—Lisinopril—dilated cardiomyopathy	0.00187	0.00306	CcSEcCtD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000937	0.00259	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000936	0.00259	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000934	0.00258	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000926	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000925	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000925	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000924	0.00255	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000923	0.00255	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000914	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000911	0.00252	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000907	0.00251	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000903	0.00249	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0009	0.00249	CbGpPWpGaD
Glycopyrrolate—CHRM4—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000899	0.00248	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000896	0.00248	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000892	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000892	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000889	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000889	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00088	0.00243	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00088	0.00243	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000868	0.0024	CbGpPWpGaD
Glycopyrrolate—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000861	0.00238	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000829	0.00229	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000826	0.00228	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000818	0.00226	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000803	0.00222	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0008	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0008	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000798	0.0022	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000792	0.00219	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00079	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000774	0.00214	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000759	0.0021	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000757	0.00209	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000749	0.00207	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000741	0.00205	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000735	0.00203	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000734	0.00203	CbGpPWpGaD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000728	0.00201	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000726	0.00201	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000715	0.00198	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000703	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000686	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000685	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000683	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000679	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000679	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000677	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000677	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000677	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00067	0.00185	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00067	0.00185	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000656	0.00181	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000651	0.0018	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00065	0.0018	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000649	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000648	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000642	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000642	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000631	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000629	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000623	0.00172	CbGpPWpGaD
Glycopyrrolate—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000617	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000616	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000611	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000609	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000606	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000604	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000603	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000599	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000598	0.00165	CbGpPWpGaD
Glycopyrrolate—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00059	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000569	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000569	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000557	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000545	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000545	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000545	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000529	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000522	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000522	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00052	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000517	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000517	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000515	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000512	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000507	0.0014	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000495	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000495	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000495	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000494	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000491	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000489	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000482	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000481	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00048	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000476	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000465	0.00129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00046	0.00127	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000452	0.00125	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000451	0.00125	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000446	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00044	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000438	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000419	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000416	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000415	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000414	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00041	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000398	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000397	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000384	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000384	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000382	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000382	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00038	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000379	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000379	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000377	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000377	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000367	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000366	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000363	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000361	0.000998	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000357	0.000986	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000356	0.000983	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000352	0.000973	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000348	0.000963	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000348	0.000963	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000347	0.00096	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000347	0.00096	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000345	0.000955	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000344	0.000952	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000344	0.00095	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000344	0.00095	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000344	0.00095	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000341	0.000942	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000329	0.00091	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000324	0.000895	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000323	0.000892	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000322	0.000891	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00032	0.000884	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000314	0.000867	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000313	0.000864	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00031	0.000857	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00031	0.000856	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000309	0.000854	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000309	0.000853	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000308	0.000851	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000305	0.000844	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000305	0.000844	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000295	0.000815	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000295	0.000815	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000294	0.000813	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000293	0.000809	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000292	0.000808	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000292	0.000808	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000291	0.000805	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000284	0.000784	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00028	0.000774	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00028	0.000773	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00028	0.000773	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000279	0.000771	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000276	0.000764	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000275	0.00076	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000272	0.000751	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000268	0.00074	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000268	0.00074	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000267	0.000738	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000264	0.000731	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000263	0.000727	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000254	0.000702	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000253	0.0007	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000251	0.000693	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000235	0.000649	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000232	0.000641	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000231	0.000639	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000229	0.000632	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000225	0.000621	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000223	0.000615	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000217	0.0006	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000217	0.000599	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000214	0.000593	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000213	0.000589	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000208	0.000574	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000207	0.000572	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000206	0.000569	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000206	0.000569	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000205	0.000567	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000205	0.000567	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000205	0.000566	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000203	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000203	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000197	0.000545	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000197	0.000544	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000195	0.000538	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000194	0.000536	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000191	0.000529	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000191	0.000529	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000191	0.000527	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000189	0.000522	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000189	0.000521	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000188	0.000519	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000186	0.000514	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000186	0.000514	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000185	0.000512	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000185	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000183	0.000506	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000183	0.000506	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000173	0.000478	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000166	0.000457	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000165	0.000456	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000158	0.000437	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000158	0.000437	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000158	0.000436	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000156	0.000432	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000151	0.000418	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00015	0.000415	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00015	0.000414	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000148	0.00041	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000147	0.000408	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000133	0.000368	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000133	0.000367	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000131	0.000362	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00013	0.00036	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000129	0.000357	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000129	0.000357	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000129	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000127	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000127	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000117	0.000322	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000116	0.000321	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000115	0.000318	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000115	0.000317	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000111	0.000308	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000111	0.000307	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.00011	0.000304	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00011	0.000303	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.97e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.94e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.86e-05	0.000245	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	7.86e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.73e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.7e-05	0.000213	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.63e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	7.53e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.3e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.28e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.23e-05	0.000145	CbGpPWpGaD
